The treatment of spasticity, i.e. increased muscle tension, with botulinum toxin is still not reimbursed despite receiving a positive recommendation from the Agency for Health Technology Assessment in 2009. on 4 July 2013, this topic was discussed by experts at the conference 'Stroke. And what next?" organised by the Brain Stroke Foundation and the Interdisciplinary Expert Group on Spasticity.